In a bleomycin-induced mouse model of scleroderma, with a shorter duration of bleomycin induction meant to simulate localized scleroderma/morphea, CXCL9 and CXCR3 knockout mice were protected from the development of fibrosis. Here, CXCL9 is linked to scleroderma.